Use of Electronic Cigarettes Among Cancer Survivors in the U.S

Ramzi G. Salloum, Kayla R. Getz, Andy S L Tan, Lisa Carter-Harris, Kelly C. Young-Wolff, Thomas J. George, Elizabeth A. Shenkman

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Introduction: The population-level patterns of electronic cigarette (e-cigarette) use among cancer survivors in the U.S. are unknown. The objective of this study was to examine the prevalence and correlates of e-cigarette use among cancer survivors in a nationally representative sample. Methods: A cross-sectional analysis was conducted of the 2014 National Health Interview Survey of the U.S. non-institutionalized civilian population. The main study outcomes were the prevalence and correlates of ever and current e-cigarette use among adults with self-reported history of cancer, excluding non-melanoma skin cancer (N=2,695). Multivariable logistic regression analyses examined whether e-cigarette use differed by cigarette smoking status and demographic subgroups. The analyses were performed in 2015. Results: The prevalence of e-cigarette use among adult cancer survivors was lower than the general population: 2.8% of cancer survivors reported currently using e-cigarettes and an additional 6.3% had previously used e-cigarettes but were not currently using them. Use of e-cigarettes was most common among cancer survivors who currently smoked cigarettes: 34.3% of current smokers were ever e-cigarette users and 15.6% were current e-cigarette users, compared with former smokers (2.7% ever and 1.4% current e-cigarette users) and never smokers (small sample/estimates unavailable). Conclusions: E-cigarettes are not part of current evidence-based smoking-cessation strategies. However, the finding that cancer survivors who currently smoke cigarettes are more likely to use e-cigarettes highlights the importance of addressing e-cigarette use in patient-provider communications around tobacco cessation.

Original languageEnglish (US)
JournalAmerican Journal of Preventive Medicine
DOIs
StateAccepted/In press - 2016

Fingerprint

Survivors
Tobacco Products
Neoplasms
Electronic Cigarettes
Tobacco Use Cessation
Population
Skin Neoplasms
Smoking Cessation
Health Surveys
Smoke
Cross-Sectional Studies
Logistic Models
Smoking
Communication
Regression Analysis
Demography
Outcome Assessment (Health Care)
Interviews

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Epidemiology

Cite this

Salloum, R. G., Getz, K. R., Tan, A. S. L., Carter-Harris, L., Young-Wolff, K. C., George, T. J., & Shenkman, E. A. (Accepted/In press). Use of Electronic Cigarettes Among Cancer Survivors in the U.S. American Journal of Preventive Medicine. https://doi.org/10.1016/j.amepre.2016.04.015

Use of Electronic Cigarettes Among Cancer Survivors in the U.S. / Salloum, Ramzi G.; Getz, Kayla R.; Tan, Andy S L; Carter-Harris, Lisa; Young-Wolff, Kelly C.; George, Thomas J.; Shenkman, Elizabeth A.

In: American Journal of Preventive Medicine, 2016.

Research output: Contribution to journalArticle

Salloum, RG, Getz, KR, Tan, ASL, Carter-Harris, L, Young-Wolff, KC, George, TJ & Shenkman, EA 2016, 'Use of Electronic Cigarettes Among Cancer Survivors in the U.S', American Journal of Preventive Medicine. https://doi.org/10.1016/j.amepre.2016.04.015
Salloum, Ramzi G. ; Getz, Kayla R. ; Tan, Andy S L ; Carter-Harris, Lisa ; Young-Wolff, Kelly C. ; George, Thomas J. ; Shenkman, Elizabeth A. / Use of Electronic Cigarettes Among Cancer Survivors in the U.S. In: American Journal of Preventive Medicine. 2016.
@article{ec658924df9d43d8836642f7f103aeac,
title = "Use of Electronic Cigarettes Among Cancer Survivors in the U.S",
abstract = "Introduction: The population-level patterns of electronic cigarette (e-cigarette) use among cancer survivors in the U.S. are unknown. The objective of this study was to examine the prevalence and correlates of e-cigarette use among cancer survivors in a nationally representative sample. Methods: A cross-sectional analysis was conducted of the 2014 National Health Interview Survey of the U.S. non-institutionalized civilian population. The main study outcomes were the prevalence and correlates of ever and current e-cigarette use among adults with self-reported history of cancer, excluding non-melanoma skin cancer (N=2,695). Multivariable logistic regression analyses examined whether e-cigarette use differed by cigarette smoking status and demographic subgroups. The analyses were performed in 2015. Results: The prevalence of e-cigarette use among adult cancer survivors was lower than the general population: 2.8{\%} of cancer survivors reported currently using e-cigarettes and an additional 6.3{\%} had previously used e-cigarettes but were not currently using them. Use of e-cigarettes was most common among cancer survivors who currently smoked cigarettes: 34.3{\%} of current smokers were ever e-cigarette users and 15.6{\%} were current e-cigarette users, compared with former smokers (2.7{\%} ever and 1.4{\%} current e-cigarette users) and never smokers (small sample/estimates unavailable). Conclusions: E-cigarettes are not part of current evidence-based smoking-cessation strategies. However, the finding that cancer survivors who currently smoke cigarettes are more likely to use e-cigarettes highlights the importance of addressing e-cigarette use in patient-provider communications around tobacco cessation.",
author = "Salloum, {Ramzi G.} and Getz, {Kayla R.} and Tan, {Andy S L} and Lisa Carter-Harris and Young-Wolff, {Kelly C.} and George, {Thomas J.} and Shenkman, {Elizabeth A.}",
year = "2016",
doi = "10.1016/j.amepre.2016.04.015",
language = "English (US)",
journal = "American Journal of Preventive Medicine",
issn = "0749-3797",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Use of Electronic Cigarettes Among Cancer Survivors in the U.S

AU - Salloum, Ramzi G.

AU - Getz, Kayla R.

AU - Tan, Andy S L

AU - Carter-Harris, Lisa

AU - Young-Wolff, Kelly C.

AU - George, Thomas J.

AU - Shenkman, Elizabeth A.

PY - 2016

Y1 - 2016

N2 - Introduction: The population-level patterns of electronic cigarette (e-cigarette) use among cancer survivors in the U.S. are unknown. The objective of this study was to examine the prevalence and correlates of e-cigarette use among cancer survivors in a nationally representative sample. Methods: A cross-sectional analysis was conducted of the 2014 National Health Interview Survey of the U.S. non-institutionalized civilian population. The main study outcomes were the prevalence and correlates of ever and current e-cigarette use among adults with self-reported history of cancer, excluding non-melanoma skin cancer (N=2,695). Multivariable logistic regression analyses examined whether e-cigarette use differed by cigarette smoking status and demographic subgroups. The analyses were performed in 2015. Results: The prevalence of e-cigarette use among adult cancer survivors was lower than the general population: 2.8% of cancer survivors reported currently using e-cigarettes and an additional 6.3% had previously used e-cigarettes but were not currently using them. Use of e-cigarettes was most common among cancer survivors who currently smoked cigarettes: 34.3% of current smokers were ever e-cigarette users and 15.6% were current e-cigarette users, compared with former smokers (2.7% ever and 1.4% current e-cigarette users) and never smokers (small sample/estimates unavailable). Conclusions: E-cigarettes are not part of current evidence-based smoking-cessation strategies. However, the finding that cancer survivors who currently smoke cigarettes are more likely to use e-cigarettes highlights the importance of addressing e-cigarette use in patient-provider communications around tobacco cessation.

AB - Introduction: The population-level patterns of electronic cigarette (e-cigarette) use among cancer survivors in the U.S. are unknown. The objective of this study was to examine the prevalence and correlates of e-cigarette use among cancer survivors in a nationally representative sample. Methods: A cross-sectional analysis was conducted of the 2014 National Health Interview Survey of the U.S. non-institutionalized civilian population. The main study outcomes were the prevalence and correlates of ever and current e-cigarette use among adults with self-reported history of cancer, excluding non-melanoma skin cancer (N=2,695). Multivariable logistic regression analyses examined whether e-cigarette use differed by cigarette smoking status and demographic subgroups. The analyses were performed in 2015. Results: The prevalence of e-cigarette use among adult cancer survivors was lower than the general population: 2.8% of cancer survivors reported currently using e-cigarettes and an additional 6.3% had previously used e-cigarettes but were not currently using them. Use of e-cigarettes was most common among cancer survivors who currently smoked cigarettes: 34.3% of current smokers were ever e-cigarette users and 15.6% were current e-cigarette users, compared with former smokers (2.7% ever and 1.4% current e-cigarette users) and never smokers (small sample/estimates unavailable). Conclusions: E-cigarettes are not part of current evidence-based smoking-cessation strategies. However, the finding that cancer survivors who currently smoke cigarettes are more likely to use e-cigarettes highlights the importance of addressing e-cigarette use in patient-provider communications around tobacco cessation.

UR - http://www.scopus.com/inward/record.url?scp=84970005606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84970005606&partnerID=8YFLogxK

U2 - 10.1016/j.amepre.2016.04.015

DO - 10.1016/j.amepre.2016.04.015

M3 - Article

C2 - 27242079

AN - SCOPUS:84970005606

JO - American Journal of Preventive Medicine

JF - American Journal of Preventive Medicine

SN - 0749-3797

ER -